HEICO Corp. 10-Q Summary: Period Ended April 30, 1995
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended April 30, 1995, and the six-month period ended on that date. HEICO Corporation operates through two primary segments: HEICO Aerospace Corporation (commercial jet engine replacement parts) and MediTek Health Corporation (medical diagnostic services). The company declared a 10% stock dividend payable in July 1995, and financial data has been restated to reflect this transaction.
Key Financial Metrics
| Metric | Six Months Ended Apr 30, 1995 | Six Months Ended Apr 30, 1994 | Three Months Ended Apr 30, 1995 | Three Months Ended Apr 30, 1994 |
|---|---|---|---|---|
| Net Sales | $19,278,000 | $14,710,000 | $10,345,000 | $7,801,000 |
| Net Income | $1,221,000 | $871,000 | $652,000 | $371,000 |
| Diluted EPS | $0.48 | $0.34 | $0.25 | $0.15 |
| Operating Cash Flow | $2,566,000 | $809,000 | N/A | N/A |
| Cash and Equivalents (End of Period) | $4,078,000 | $3,031,000 | N/A | N/A |
| Total Debt (Current + Long-term) | $8,459,000 | $5,456,000 | N/A | N/A |
| Aerospace Gross Margin (6mo) | 31.4% | 26.9% | N/A | N/A |
| MediTek Gross Margin (6mo) | 34.3% | 31.4% | N/A | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 31% year-over-year for the six-month period, driven by a 33% increase in Aerospace sales and a 28% increase in MediTek sales.
- Profitability: Net income rose 40% year-over-year. Excluding a one-time accounting change benefit in the prior year, net income increased 149%.
- Margin Expansion: Both segments reported improved gross margins due to higher sales volumes of higher-margin products (Aerospace) and improved center performance (MediTek).
- Expense Management: Selling, general, and administrative (SG&A) expenses increased in absolute dollars but declined as a percentage of sales from 23.3% to 20.7% year-over-year.
- Debt Levels: Total debt increased significantly, primarily due to additional debt associated with MediTek center acquisitions and operations.
Outlook, Risks, and Management Commentary
- Backlog: HEICO Aerospace backlog increased to $14.3 million, up $2.7 million from the prior year, driven by commercial airline orders.
- Legal Contingency (MediTek): A Florida state court ruled that state-imposed fee caps on diagnostic imaging are unconstitutional. While currently unenforceable, the State is expected to appeal. If reversed or reinstated retroactively, this could materially adversely impact MediTek, which generated 46% of its operating income from Florida.
- Partnership Losses: Equity in losses from unconsolidated partnerships increased due to lower sales volumes at partnership centers, partially offsetting consolidated gains.
- Capital Allocation: The company utilized cash for short-term investments, contingent note payments for acquisitions, and repurchased 13,000 shares of common stock.
Investor Verification Checklist
- Verify the status of the Florida State Court appeal regarding fee caps and potential retroactive application.
- Confirm the sustainability of the 31.4% gross margin in the Aerospace segment given the mix of commercial jet engine parts.
- Review the specific terms of the contingent note payments related to MediTek acquisitions to assess future cash outflow obligations.
- Monitor the impact of the 10% stock dividend on share count and per-share metrics in subsequent filings.
- Assess the trend in "Equity in loss of unconsolidated partnerships" to determine if partnership performance is stabilizing.